Overview
Tomokazu Nakagawa practices practicing medicine in Kawahara, Japan.
Their clinical expertise encompasses Primary Lateral Sclerosis, Palatal Myoclonus, and Drug Induced Dyskinesia.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tomokazu Nakagawa
Is Tomokazu Nakagawa a top-rated expert for Primary Lateral Sclerosis?
MediFind is an objective health platform that identifies experts based on real-world data. Tomokazu Nakagawa is classified as an Experienced expert for Primary Lateral Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tomokazu Nakagawa participate in research or clinical trials?
Yes. Tomokazu Nakagawa has published 8 articles and abstracts on conditions like Primary Lateral Sclerosis. You can view a list of Tomokazu Nakagawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Drug Induced DyskinesiaNakagawa isExperienced. Learn about Drug Induced Dyskinesia.
- Palatal MyoclonusNakagawa isExperienced. Learn about Palatal Myoclonus.
- Primary Lateral SclerosisNakagawa isExperienced. Learn about Primary Lateral Sclerosis.